ArticleBMC geriatrics2026
Linking dementia prodromes and cancer through motor function impairment: the Rotterdam-Study.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundFindings on the relation between dementia and cancer have been inconsistent and influenced by methodological biases. Hypothesising that studying preclinical brain dysfunction may better unmask this link, we investigated the association of cancer with motoric cognitive risk syndrome (MCRS), an established dementia prodrome combining slow gait with subjective cognitive complaints.
methodsWe included 2590 participants from the Rotterdam Study (2009-2015), free of dementia and prevalent cancer at baseline, with gait and cognitive assessment data to define MCRS and mild cognitive impairment (MCI). Cox proportional Hazard models examined the relation of MCRS, MCI, global gait, and individual gait domains with risk of cancer, adjusting for covariates.
resultsIndividuals with MCRS tended to have an increased risk of cancer (HR: 1.26, 95% CI: 0.88-1.80), primarily driven by slow gait. Similarly, individuals with MCI tended to have an increased risk of cancer (HR: 1.29, 95% CI: 0.82-2.04), primarily driven by objective cognitive impairment. Worse global gait conveyed a slightly increased risk of cancer (standardised HR: 1.10, 95% CI: 0.99-1.22), driven by Rhythm, Phases and Variability, with a stronger effect when follow-up was truncated at 3 years (standardised HR: 1.22, 95% CI: 1.03-1.45).
conclusionsBoth individuals with MCRS and individuals with MCI tended to have an increased risk of cancer, supporting the notion of shared mechanisms between neurodegeneration and cancer. The association with gait impairment was most pronounced in the years preceding diagnosis, suggesting subclinical disease may partly underlie this link. These findings highlight motor-cognitive prodromes as informative phenotypes for studying shared vulnerability across neurodegenerative and oncological diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.